| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |